Generic Drugs Market Report Overview 2018, Demand By Share, Size, Regional Insights, Industry Trends, Growth, And Key Players Forecast 2023

1
    Global Generic Drugs Market Propelled by
Growing Awareness Amongst Consumers

Copyright IMARC. All Rights Reserved
2
About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
  Global Generic Drugs Market Propelled by
Growing Awareness Amongst Consumers Over the
recent years, the global generic drugs market has
been witnessing a healthy growth. Some of the
factors which are bolstering the market include
low capital investment, approval from FDA or
other assigned authority and encouragement from
the government. Generic drugs are considered as
bioequivalent of branded drugs as they are
similar in terms of quality, strength, dosage and
intended use. They require low capital investment
as they only incur the manufacturing cost without
the expenditure on drug discovery, drug
development, advertising, distribution of free
samples, etc. This results in an overall
reduction of the generic drug manufacturing
prices. On account of this, generic drugs form an
integral part of the public healthcare schemes,
in both the developed as well as developing
countries. A new research report by IMARC Group,
titled Generic Drugs Market Global Industry
Trends, Manufacturing Process, Share, Size,
Growth, Opportunity and Forecast 2018-2023,
estimates that the global generic drugs
market was worth around US 315 Billion in 2017.
The report further expects the market to reach
US 474 Billion by 2023, at a projected CAGR of
6.8 over the forecast period.
4
Report Description and Highlights
Report Description

• Global Generic Drugs Market Drivers/Constraints
• As compared to the branded drugs, generic drugs
  are regarded cost-effective as they are 40-60
  cheaper. This acts as one of the vital factors
  which is augmenting the demand for generic drugs
  across the globe.
• Generic drugs are completely safe and reliable as
  they are inspected, approved and regulated by the
  FDA or other assigned authorities. This coupled
  with growing awareness about generic drugs has
  facilitated the growth of the market.
• Governments of several nations are encouraging
  the use of generic drugs so as to reduce the
  expenditure incurred on the healthcare sector. In
  line with this, various campaigns are being
  undertaken with the objective of substituting the
  branded drugs with generic drugs.
• A rise in the number of chronic diseases like
  diabetes, cardiovascular diseases, Parkinsons
  disease, Alzheimers disease, etc. is further
  creating opportunities for the generic drug
  manufacturers, particularly in countries with an
  increasing geriatric population.
• There are some factors which are hampering the
  growth of the generic drugs market. For instance,
  these drugs are perceived inferior by few
  consumers as they contain different inactive
  ingredients.
• Read more here http//bit.ly/2ywjaVx

5
Report Description and Highlights
Report Description

•  
• Regional Insights
• On a geographical front, the market has been
  segmented as United States, China, Brazil,
  Germany, France, India, United Kingdom, Japan,
  Canada, Italy and Others. Presently, the United
  States exhibits a clear dominance in the market
  on account of rising lifestyle diseases in the
  region.
• Competitive Landscape
• The market is fragmented in nature owing to the
  presence of numerous small and large
  manufacturers who are competing in terms of
  prices. There is a high competition in the market
  which makes it tough for small players to
  survive.
• Some of the leading players operating in the
  market are
• Teva Pharmaceuticals
• Novartis Sandoz
• Mylan
• Fresenius
• Pfizer

6
Report Description and Highlights
Want more information about this market? Request
a free report sample https//www.imarcgroup.com/r
equest?typereportid549flagB Browse More
Related Reports  HIV Drugs Market
http//bit.ly/2OrLPpn GCC Generic Drug Market
http//bit.ly/2Pk9jMU
7
Report Description and Highlights
Report Description

2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
8

Contact Us